Abstract
Arterial spin labeling (ASL) perfusion MRI has been increasingly used in Alzheimer's Disease (AD) research. However, ASL MRI sequences differ greatly in terms of arterial blood signal preparations and data acquisition strategies, both leading to a large difference of signal-to-noise ratio (SNR). It is of great translational importance to compare the several widely used ASL MRI sequences regarding sensitivity of ASL measured cerebral blood flow (CBF) for detecting the between-group difference across the AD continuum. To this end, this study compared three ASL MRI sequences in AD research, including the 2D Pulsed ASL (PASL), 3D Background Suppressed (BS) PASL, and 3D BS Pseudo-Continuous ASL (PCASL). We used data from 100 healthy and cognitively normal elderly control (NC) subjects, 75 patients with mild cognitive impairment (MCI), and 57 Alzheimer’s disease (AD) subjects from the AD neuroimaging initiative (ADNI). Both cross-sectional perfusion difference and perfusion versus clinical assessment correlations were examined. The major findings included: 3D PCASL sequence identified stronger patient versus control CBF/rCBF differences than 2D PASL and 3D PASL; MCI showed reduced CBF and CBF redistribution; CBF in orbito-frontal cortex presents a new U-shape change pattern from normal aging to MCI and to AD; 3D PCASL identified a negative rCBF to memory correlation while 2D PASL showed a positive correlation.
Similar content being viewed by others
Data availability
ADNI data are freely available from https://adni.loni.usc.edu/. ASLtbx is freely available from https://cfn.upenn.edu/zewang/ASLtbx.php and https://github.com/zewangnew/ASLtbx.
References
Alsop, D. C., Detre, J. A., & Grossman, M. (2000). Assessment of cerebral blood flow in Alzheimer’s disease by spin-labeled magnetic resonance imaging. Annals of Neurology, 47(1), 93–100.
Alsop, D. C., Casement, M., de Bazelaire, C., Fong, T., & Press, D. Z. (2008). Hippocampal hyperperfusion in Alzheimer’s disease. Neuroimage, 42(4), 1267–1274. https://doi.org/10.1016/j.neuroimage.2008.06.006
Alsop, D. C., Dai, W., Grossman, M., & Detre, J. A. (2010). Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer’s disease. Journal of Alzheimer’s Disease: JAD, 20(3), 871–880. https://doi.org/10.3233/JAD-2010-091699
Alsop, D. C., Detre, J. A., Golay, X., Gunther, M., Hendrikse, J., Hernandez-Garcia, L., Lu, H., Macintosh, B. J., Parkes, L. M., Smits, M., van Osch, M. J., Wang, D. J., Wong, E. C., & Zaharchuk, G. (2014). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.25197
Baron, J. C., Lebrun-Grandie, P., Collard, P., Crouzel, C., Mestelan, G., & Bousser, M. G. (1982). Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. Journal of Nuclear Medicine, 23(5), 391–399. http://www.ncbi.nlm.nih.gov/pubmed/6978932.
Binnewijzend, M. A., Kuijer, J. P., Benedictus, M. R., van der Flier, W. M., Wink, A. M., Wattjes, M. P., van Berckel, B. N., Scheltens, P., & Barkhof, F. (2013). Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology, 267(1), 221–230. https://doi.org/10.1148/radiol.12120928
Camargo, A., & Wang, Z. (2022).Estimating Arterial Transit Time (ATT) From ASL MRI Acquired at A Single Post-Labeling-Delay Time 2022 Annual Meeting of the International Society of Magnetic Resonance in Medicine, London.
Camargo, A., Wang, Z., Alzheimer’s Disease Neuroimaging, I. (2021). Longitudinal cerebral blood flow changes in normal aging and the Alzheimer’s disease continuum identified by arterial spin labeling MRI. Journal of Alzheimer’s Disease, 81(4), 1727–1735. https://doi.org/10.3233/JAD-210116
Chao, L. L., Pa, J., Duarte, A., Schuff, N., Weiner, M. W., Kramer, J. H., Miller, B. L., Freeman, K. M., & Johnson, J. K. (2009). Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Disease and Associated Disorder, 23(3), 245–252. https://doi.org/10.1097/WAD.0b013e318199ff46
Chelune, G. J., Bornstein, R. A., & Prifitera, A. (1990). The Wechsler memory scale—revised. Advances in Psychological Assessment. Boston, MA: Springer. https://doi.org/10.1007/978-1-4613-0555-2_3
Dai, W., Garcia, D., de Bazelaire, C., & Alsop, D. C. (2008). Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magnetic Resonance in Medicine, 60(6), 1488–1497. https://doi.org/10.1002/mrm.21790
Dai, W., Lopez, O. L., Carmichael, O. T., Becker, J. T., Kuller, L. H., & Gach, H. M. (2009). Mild cognitive impairment and alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology, 250(3), 856–866. https://doi.org/10.1148/radiol.2503080751
Detre, J. A., Leigh, J. S., Williams, D. S., & Koretsky, A. P. (1992). Perfusion imaging. Magnetic Resonance in Medicine, 23, 37–45.
Detre, J. A., Wang, J., Wang, Z., & Rao, H. (2009). Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Current Opinion in Neurology, 22(4), 348–355. https://doi.org/10.1097/WCO.0b013e32832d9505
Detre, J. A., Rao, H., Wang, D. J., Chen, Y. F., & Wang, Z. (2012). Applications of arterial spin labeled MRI in the brain. Journal of Magnetic Resonance Imaging, 35(5), 1026–1037.
DeWitt, D. S., Yuan, X. Q., Becker, D. P., & Hayes, R. L. (1988). Simultaneous, quantitative measurement of local blood flow and glucose utilization in tissue samples in normal and injured feline brain. Brain Injury, 2(4), 291–303. http://www.ncbi.nlm.nih.gov/pubmed/3203175
Dolui, S., Vidorreta, M., Wang, Z., Nasrallah, I. M., Alavi, A., Wolk, D. A., & Detre, J. A. (2017). Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment. Hum Brain Mapp. https://doi.org/10.1002/hbm.23732
Du, A. T., Jahng, G. H., Hayasaka, S., Kramer, J. H., Rosen, H. J., Gorno-Tempini, M. L., Rankin, K. P., Miller, B. L., Weiner, M. W., & Schuff, N. (2006). Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology, 67(7), 1215–1220. https://doi.org/10.1212/01.wnl.0000238163.71349.78
Duan, W., Zhou, G. D., Balachandrasekaran, A., Bhumkar, A. B., Boraste, P. B., Becker, J. T., Kuller, L. H., Lopez, O. L., Gach, H. M., & Dai, W. (2021). Cerebral blood flow predicts conversion of mild cognitive impairment into Alzheimer’s disease and cognitive decline: An arterial spin labeling follow-up study. Journal of Alzheimer’s Disease, 82(1), 293–305.
Fernandez-Seara, M. A., Wang, Z., Wang, J., Rao, H. Y., Guenther, M., Feinberg, D. A., & Detre, J. A. (2005). Continuous arterial spin labeling perfusion measurements using single shot 3D GRASE at 3 T. Magnetic Resonance in Medicine, 54(5), 1241–1247. https://doi.org/10.1002/mrm.20674
Fortin, J.-P., Parker, D., Tunç, B., Watanabe, T., Elliott, M. A., Ruparel, K., Roalf, D. R., Satterthwaite, T. D., Gur, R. C., & Gur, R. E. (2017). Harmonization of multi-site diffusion tensor imaging data. NeuroImage, 161, 149–170.
Furlow, T. W., Jr., Martin, R. M., & Harrison, L. E. (1983). Simultaneous measurement of local glucose utilization and blood flow in the rat brain: an autoradiographic method using two tracers labeled with carbon-14. Journal of Cerebral Blood Flow and Metabolism, 3(1), 62–66. https://doi.org/10.1038/jcbfm.1983.7
Gunther, M., Oshio, K., & Feinberg, D. A. (2005). Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magnetic Resonance in Medicine, 54(2), 491–498. https://doi.org/10.1002/mrm.20580
Gunther, M. (2007).Highly efficient accelerated acquisition of perfusion inflow series by cycled arterial spin labeling Annual Meeting of International Society of Magnetic Resonance in Medicine, Berlin.
Haller, S., Zaharchuk, G., Thomas, D. L., Lovblad, K.-O., Barkhof, F., & Golay, X. (2016). Arterial spin labeling perfusion of the brain: Emerging clinical applications. Radiology, 281(2), 337–356.
Hu, W. T., Wang, Z., Lee, V. M., Trojanowski, J. Q., Detre, J. A., & Grossman, M. (2010). Distinct cerebral perfusion patterns in FTLD and AD. Neurology, 75(10), 881–888. https://doi.org/10.1212/WNL.0b013e3181f11e35
Jacobs, H. I., Hopkins, D. A., Mayrhofer, H. C., Bruner, E., van Leeuwen, F. W., Raaijmakers, W., & Schmahmann, J. D. (2018). The cerebellum in Alzheimer’s disease: Evaluating its role in cognitive decline. Brain : A Journal of Neurology, 141(1), 37–47.
Jahn, H. (2013). Memory loss in Alzheimer’s disease. Dialogues in Clinical Neuroscience, 15(4), 445–454. https://doi.org/10.31887/DCNS.2013.15.4/hjahn
Jezzard, P., Chappell, M. A., & Okell, T. W. (2018). Arterial spin labeling for the measurement of cerebral perfusion and angiography. Journal of Cerebral Blood Flow and Metabolism, 38(4), 603–626. https://doi.org/10.1177/0271678X17743240
Joris, P. J., Mensink, R. P., Adam, T. C., & Liu, T. T. (2018). Cerebral blood flow measurements in adults: A review on the effects of dietary factors and exercise. Nutrients, 10(5), 530.
Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., Aisen, P. S., Weiner, M. W., Jagust, W. J., Initiative, A., & s. D. N. (2012). Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology, 72(4), 578–586.
Leeuwis, A. E., Benedictus, M. R., Kuijer, J. P., Binnewijzend, M. A., Hooghiemstra, A. M., Verfaillie, S. C., Koene, T., Scheltens, P., Barkhof, F., & Prins, N. D. (2017). Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer’s disease. Alzheimer’s and Dementia, 13(5), 531–540.
Leeuwis, A. E., Smith, L. A., Melbourne, A., Hughes, A. D., Richards, M., Prins, N. D., Sokolska, M., Atkinson, D., Tillin, T., & Jäger, H. R. (2018). Cerebral blood flow and cognitive functioning in a community-based, multi-ethnic cohort: The SABRE study. Front Aging Neurosci, 10, 279.
Li, Y., Dolui, S., Xie, D. F., Wang, Z., Alzheimer’s Disease Neuroimaging, I. (2018). Priors-guided slice-wise adaptive outlier cleaning for arterial spin labeling perfusion MRI. Journal of Neuroscience Methods, 307, 248–253. https://doi.org/10.1016/j.jneumeth.2018.06.007
Liu, Z. M., Schmidt, K. F., Sicard, K. M., & Duong, T. Q. (2004). Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia. Magnetic resonance in medicine, 52(2), 277–285. https://doi.org/10.1002/mrm.20148
Liu, Y., Zhu, X., Feinberg, D., Guenther, M., Gregori, J., Weiner, M. W., & Schuff, N. (2012). Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics. Magnetic Resonance in Medicine, 68(3), 912–922.
Lövblad, K.-O., Montandon, M.-L., Viallon, M., Rodriguez, C., Toma, S., Golay, X., Giannakopoulos, P., & Haller, S. (2015). Arterial spin-labeling parameters influence signal variability and estimated regional relative cerebral blood flow in normal aging and mild cognitive impairment: FAIR versus PICORE techniques. American Journal of Neuroradiology, 36(7), 1231–1236.
Luis Hernandez-Garcia, V. A., Dai, W., Fernandez-Seara, M. A., Guo, J., Guenther, M., Schollenberger, J., Madhuranthakam, A. J., Mutsaerts, H., Petr, J., Qin, Q., Suzuki, Y., Taso, M., Thomas, D. L., van Osch, M. J. P., Woods, J. G., Zhao, M. Y., Yan, L., Wang, Z., Zhao, L., … ISMRM Perfusion Study Group. (2022). Recent technical developments in ASL: A review of the state of the art. Magnetic Resonance in Medicine, 88(5), 2021–2042. https://doi.org/10.1002/mrm.29381
MacIntosh, B. J., Filippini, N., Chappell, M. A., Woolrich, M. W., Mackay, C. E., & Jezzard, P. (2010). Assessment of arterial arrival times derived from multiple inversion time pulsed arterial spin labeling MRI. Magnetic Resonance in Medicine, 63(3), 641–647.
Musiek, E. S., Chen, Y., Korczykowski, M., Saboury, B., Martinez, P. M., Reddin, J. S., Alavi, A., Kimberg, D. Y., Wolk, D. A., Julin, P., Newberg, A. B., Arnold, S. E., & Detre, J. A. (2012). Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 8(1), 51–59. https://doi.org/10.1016/j.jalz.2011.06.003
Mutsaerts, H. J., Steketee, R. M., Heijtel, D. F., Kuijer, J. P., van Osch, M. J., Majoie, C. B., Smits, M., & Nederveen, A. J. (2014). Inter-vendor reproducibility of pseudo-continuous arterial spin labeling at 3 Tesla. PLoS ONE, 9(8), e104108.
Mutsaerts, H. J., van Osch, M. J., Zelaya, F. O., Wang, D. J., Nordhoy, W., Wang, Y., Wastling, S., Fernandez-Seara, M. A., Petersen, E. T., Pizzini, F. B., Fallatah, S., Hendrikse, J., Geier, O., Gunther, M., Golay, X., Nederveen, A. J., Bjornerud, A., & Groote, I. R. (2015). Multi-vendor reliability of arterial spin labeling perfusion MRI using a near-identical sequence: Implications for multi-center studies. NeuroImage, 113, 143–152. https://doi.org/10.1016/j.neuroimage.2015.03.043
Nanjappa, M., Troalen, T., Pfeuffer, J., Maréchal, B., Hilbert, T., Kober, T., Schneider, F. C., Croisille, P., & Viallon, M. (2021). Comparison of 2D simultaneous multi-slice and 3D GRASE readout schemes for pseudo-continuous arterial spin labeling of cerebral perfusion at 3 T. Magnetic Resonance Materials in Physics, Biology and Medicine, 34(3), 437–450.
Qin, Q., Alsop, D. C., Bolar, D. S., Hernandez-Garcia, L., Meakin, J., Liu, D., Nayak, K. S., Schmid, S., van Osch, M. J., & Wong, E. C. (2022). Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation. Magnetic Resonance in Medicine, 88(4), 1528–1547.
Qin Qin, D. C. A., Bolar, D. S., Hernandez-Garcia, L., Meakin, J., Liu, D., Nayak, K. S., Schmid, S., van Osch, M. J. P., Wong, E. C., Woods, J. G., Zaharchuk, G., Zhao, M. Y., Zun, Z., Guo, J., ISMRM Perfusion Study Group. (2022). Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.29371
Raichle, M. E. (1998). Behind the scenes of functional brain imaging: a historical and physiological perspective. Proceedings of the National Academy of Sciences of the United States of America, 95(3), 765–772. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9448239
Solis, E., Jr., Hascup, K. N., & Hascup, E. R. (2020). Alzheimer’s disease: The link between amyloid-β and neurovascular dysfunction. Journal of Alzheimer’s Disease, 76(4), 1179–1198.
Steketee, R. M., Mutsaerts, H. J., Bron, E. E., Van Osch, M. J., Majoie, C. B., Van Der Lugt, A., Nederveen, A. J., & Smits, M. (2015). Quantitative functional arterial spin labeling (fASL) MRI–sensitivity and reproducibility of regional CBF changes using pseudo-continuous ASL product sequences. PLoS ONE, 10(7), e0132929.
Stillman, C. M., Jakicic, J., Rogers, R., Alfini, A. J., Smith, J. C., Watt, J., Kang, C., & Erickson, K. I. (2021). Changes in cerebral perfusion following a 12-month exercise and diet intervention. Psychophysiology, 58(7), e13589.
Sun, M., Wang, Y.-L., Li, R., Jiang, J., Zhang, Y., Li, W., Zhang, Y., Jia, Z., Chappell, M., & Xu, J. (2022). Potential diagnostic applications of multi-delay arterial spin labeling in early Alzheimer’s disease: The Chinese imaging, biomarkers, and lifestyle study. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.934471
Swinford CG, Risacher SL, Wu YC, Apostolova LG, Gao S, Bice PJ, Saykin AJ. (2022). Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review. Brain Imaging and Behavior. https://doi.org/10.1007/s11682-022-00750-6
Telischak, N. A., Detre, J. A., & Zaharchuk, G. (2015). Arterial spin labeling MRI: Clinical applications in the brain. Journal of Magnetic Resonance Imaging, 41(5), 1165–1180.
Tsujikawa, T., Kimura, H., Matsuda, T., Fujiwara, Y., Isozaki, M., Kikuta, K.-I., & Okazawa, H. (2016). Arterial transit time mapping obtained by pulsed continuous 3D ASL imaging with multiple post-label delay acquisitions: Comparative study with PET-CBF in patients with chronic occlusive cerebrovascular disease. PLoS ONE, 11(6), e0156005.
Vestergaard, M. B., Lindberg, U., Aachmann-Andersen, N. J., Lisbjerg, K., Christensen, S. J., Law, I., Rasmussen, P., Olsen, N. V., & Larsson, H. B. (2016). Acute hypoxia increases the cerebral metabolic rate - a magnetic resonance imaging study. Journal of Cerebral Blood Flow and Metabolism, 36(6), 1046–1058. https://doi.org/10.1177/0271678X15606460
Vidorreta, M., Wang, Z., Rodriguez, I., Pastor, M. A., Detre, J. A., & Fernandez-Seara, M. A. (2012). Nov 7). Comparison of 2D and 3D single-shot ASL perfusion fMRI sequences. NeuroImage, 66C, 662–671. https://doi.org/10.1016/j.neuroimage.2012.10.087
Vidorreta, M., Balteau, E., Wang, Z., De Vita, E., Pastor, M. A., Thomas, D. L., Detre, J. A., & Fernandez-Seara, M. A. (2014). Evaluation of segmented 3D acquisition schemes for whole-brain high-resolution arterial spin labeling at 3 T. NMR in Biomedicine, 27(11), 1387–1396. https://doi.org/10.1002/nbm.3201
Vidorreta, M., Wang, Z., Chang, Y. V., Wolk, D. A., Fernandez-Seara, M. A., & Detre, J. A. (2017). Whole-brain background-suppressed pCASL MRI with 1D-accelerated 3D RARE Stack-Of-Spirals readout. PLoS One, 12(8), e0183762. https://doi.org/10.1371/journal.pone.0183762
Wang, Z. (2012). Improving cerebral blood flow quantification for arterial spin labeled perfusion MRI by removing residual motion artifacts and global signal fluctuations. Magnetic Resonance Imaging, 30(10), 1409–1415. https://doi.org/10.1016/j.mri.2012.05.004
Wang, Z. (2014). Characterizing early Alzheimer’s disease and disease progression using hippocampal volume and arterial spin labeling perfusion MRI. Journal of Alzheimer’s Disease, 42, S495–S502. https://doi.org/10.3233/Jad-141419
Wang, Z. (2022). Arterial spin labeling perfusion MRI signal processing through traditional methods and machine learning. Investigative Magnetic Resoance Imaging, 26(4), 220–228. https://doi.org/10.13104/imri.2022.26.4.220
Wang, Z., Aguirre, G. K., Rao, H., Wang, J., Fernández-Seara, M. A., Childress, A. R., & Detre, J. A. (2008). Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magnetic Resonance Imaging, 26(2), 261–269. PMC2268990.
Wells, J. A., Lythgoe, M. F., Gadian, D. G., Ordidge, R. J., & Thomas, D. L. (2010). In vivo Hadamard encoded continuous arterial spin labeling (H-CASL). Magnetic Resonance in Medicine, 63(4), 1111–1118. https://doi.org/10.1002/mrm.22266
Wolk, D. A., & Detre, J. A. (2012). Arterial spin labeling MRI: an emerging biomarker for Alzheimer’s disease and other neurodegenerative conditions [Research Support, N.I.H., Extramural]. Current Opinion in Neurology, 25(4), 421–428. https://doi.org/10.1097/WCO.0b013e328354ff0a
Wu, W. C., Fernandez-Seara, M., Detre, J. A., Wehrli, F. W., & Wang, J. (2007). A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magnetic Resonance in Medicine, 58(5), 1020–1027. https://doi.org/10.1002/mrm.21403
Xu, G., Rowley, H. A., Wu, G., Alsop, D. C., Shankaranarayanan, A., Dowling, M., Christian, B. T., Oakes, T. R., & Johnson, S. C. (2010). Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR Biomed, 23(3), 286–293. https://doi.org/10.1002/nbm.1462
Ze Wang, S. R. D., Xie, S. X., Arnold, S. E., Detre, J. A., Wolk, D. A., for the Alzheimer’s Disease Neuroimaging Initiative. (2013). Arterial spin labeled MRI in prodromal Alzheimer’s disease: A multi-site study. Neuroimage: Clinical, 2, 630–636.
Zlokovic, B. V. (2005). Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends in Neuroscience, 28(4), 202–208. https://doi.org/10.1016/j.tins.2005.02.001
Acknowledgements
Data collection and sharing for this project were funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuroimaging at the University of Southern California.
Funding
This work was supported by NIH grants: R01AG060054, R01AG070227, R01EB031080-01A1, R21AG082345, P41EB029460-01A1, 1UL1TR003098.
Author information
Authors and Affiliations
Consortia
Contributions
AC downloaded the data, analyzed, and interpreted the data, and wrote the initial version of the manuscript. ZW designed the study, interpreted the results, wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
Subject recruitment and data acquisition were approved by the Internal Review Boards for the parent ADNI project. All human subjects provided written consent forms before participating the ADNI study. Data re-analysis for this study was approved by Internal Review Board of University of Maryland Baltimore.
Competing interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Camargo, A., Wang, Z. & for the Alzheimer’s Disease Neuroimaging Initiative. Hypo- and hyper-perfusion in MCI and AD identified by different ASL MRI sequences. Brain Imaging and Behavior 17, 306–319 (2023). https://doi.org/10.1007/s11682-023-00764-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-023-00764-8